GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Preferred Dividends

Accelerated Pharma (Accelerated Pharma) Preferred Dividends : $0.00 Mil (TTM As of Mar. 2017)


View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Accelerated Pharma's preferred dividends for the three months ended in Mar. 2017 was $0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Mar. 2017 was $0.00 Mil.


Accelerated Pharma Preferred Dividends Historical Data

The historical data trend for Accelerated Pharma's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Preferred Dividends Chart

Accelerated Pharma Annual Data
Trend Dec14 Dec15 Dec16
Preferred Dividends
- - -

Accelerated Pharma Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Preferred Dividends Get a 7-Day Free Trial - - - - -

Accelerated Pharma Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.


Accelerated Pharma  (NAS:ACCP) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Accelerated Pharma (Accelerated Pharma) Business Description

Traded in Other Exchanges
N/A
Address
Website
Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines